Back

Multiple musculoskeletal procedures and the associated risk of amyloidosis. A Danish nationwide cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Improving diagnosis of cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Navid Noory

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Diagnostic prediction model for cardiac amyloidosis due to transthyretin: Insights from the Brazilian multicenter REACT-SP registry
Doctor K. Rafael De Paula Morales (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Amyloid cardiomyopathy: specificities of transthyretin v30 mutation compared to wild type forms
Doctor M. Pereira Santos (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Misdiagnosis rates in ATTR-CM patients and associated symptoms
Mr P. Collins (London, GB)
Abstract Slides Video
Presentation thumbnail
Impact of genetic testing family screening in hereditary transthyretin amyloidosis
Doctor N. Mora Ayestaran (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis of diagnostic performance of various echocardiographic parameters in cardiac amyloidosis.
Doctor S. Bouloukou (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Improving diagnosis of cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
ATTR cardiac amyloidosis after lumbar spinal stenosis- a prospective cohort study
thumbnail
Congress Presentation
Temporal trends and outcomes of amyloidosis in Korea: a 13-year nationwide cohort study with a focus on cardiac involvement
thumbnail
Congress Presentation
Diagnostic, therapeutic and prognostic implications of carpal tunnel syndrome and spinal stenosis in wild-type transthyretin cardiac amyloidosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources